SCHEMBL32665148

SCHEMBL32665148

CC(C)(C)OC(=O)NCc1cc(F)c(O)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.42
SERPINE1 P05121 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNA1B Q00975 1/20 0.41
CACNA1C Q13936 1/20 0.41
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39
HDAC1 Q13547 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
NQO2 P16083 1/20 0.39
KCNA5 P22460 1/20 0.39
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24476968 0.86 MTNR1A (0.48) KDM4ASERPINE1MTNR1AMTNR1B
SCHEMBL2002789 0.84 KDM4A (0.41) KDM4ASERPINE1CACNA1HCACNA1BCACNA1C
SCHEMBL25574990 0.84 AAK1 (0.49) KDM4ACACNA1HCACNA1BCACNA1CCA12
SCHEMBL22482387 0.82 KDM4A (0.44) KDM4ASERPINE1CACNA1HCACNA1BCACNA1C
SCHEMBL29675308 0.82 KDM4A (0.44) KDM4ASERPINE1CACNA1HCACNA1BCACNA1C
SCHEMBL2004184 0.82 BRD9 (0.41) KDM4ACACNA1HCACNA1BCACNA1CCA12
SCHEMBL4894133 0.81 NQO2 (0.49) KDM4ANQO2KCNA5EPHX2NR1H4
SCHEMBL24885830 0.81 NQO2 (0.49) KDM4ANQO2KCNA5CTSSCTSK
SCHEMBL29467997 0.81 KDM4A (0.41) KDM4ASERPINE1CACNA1HCACNA1BCACNA1C
SCHEMBL3154474 0.81 TRPA1 (0.46) KDM4ACACNA1HCACNA1BCACNA1CKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A KDM4A 4180/4885SERPINE1 3684/4885CACNA1H 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.